Chromosome analysis of bone marrow in mammals after treatment with isoniazid
| Autor: | Mittenburger Hg, Fränz J, H. Frohberg, Okimoto S, I. H. Pawlowitzki, G. Röhrborn, D. Müller, Schencking Ms, A. Grafe, H. Träger, Strasser Ff, Nautsch C |
|---|---|
| Rok vydání: | 1978 |
| Předmět: |
Male
Time Factors Physiology Chromosomes Chinese hamster Mice Chromosome analysis Bone Marrow Cricetinae Isoniazid Genetics medicine Animals Metaphase Genetics (clinical) Chromosome Aberrations biology Incidence (epidemiology) biology.organism_classification Rats medicine.anatomical_structure Karyotyping Immunology Standard protocol Female Critical range Bone marrow After treatment medicine.drug |
| Zdroj: | Human Genetics. 42:15-25 |
| ISSN: | 1432-1203 0340-6717 |
| DOI: | 10.1007/bf00291618 |
| Popis: | Cytogenetic investigations in bone marrow from animals treated with isoniazid (INH) were performed in seven different laboratories according to a standard protocol. The experiments were carried out in the Chinese hamster, the mouse, and the rat. In short-term studies INH was administered twice at an interval of 24 h in doses of 5, 25, and 125 mg/kg, and the animals were sacrificed 6, 12, 24, and 48 h after the second dose. In long-term studies doses of 25 and 125 mg/kg were administered thrice weekly for 12 weeks. As a rule, each group consisted of at least four animals, and 100 metaphases per animal were counted. Statistical analysis of the data showed that the incidence of chromosomal aberrations including gaps lay in the critical range for two groups in one laboratory and was significantly higher than in the control in three groups in another of the seven laboratories. From the results of both the short-term and the long-term studies in all laboratories, however, it may be concluded, that isoniazid does not induce gross chromosomal aberrations. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink